Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
From Jan 2020: how each company's value moved, whatever its size.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | Alcon Inc.✕ ALC · #705 in the world | electroCore, Inc.✕ ECOR · #19,820 in the world |
|---|---|---|
| Profile | ||
| Country | 🇨🇭 Switzerland | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments | Medical Instruments |
| Founded | 1945 | — |
| Size | ||
| Market cap | ||
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | Alcon Inc. | electroCore, Inc. |
|---|---|---|
| 2025 | $10.4 BSEC | $32 MSEC |
| 2024 | $9.9 BSEC | $25 MSEC |
| 2023 | $9.5 BSEC | $16 MSEC |
| 2022 | $8.7 BSEC | $9 MSEC |
| 2021 | $8.3 BSEC | $5 MSEC |
| 2020 | $6.8 BSEC | $4 MSEC |
| 2019 | $7.5 BSEC | $2 MSEC |
| 2018 | $7.2 BSEC | $1 MSEC |
| 2017 | $6.8 BSEC | $1 MSEC |
| 2010 | $7.2 BSEC | — |
| 2009 | $6.5 BSEC | — |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| $37.1 B |
| $75 M |
| Revenue | $10.4 B | $32 M |
|---|
| Net income | $980 M▲ best | $-14 M |
|---|
| Employees | 25,000 | 83 |
|---|
| Valuation | ||
|---|---|---|
| P/E ratio | 37.9× | — |
| Price to sales | 3.6× | 2.0× |
| Price to book | 1.7× | — |
| Free cash flow yield | 4.7%▲ best | -11.0% |
| Profitability | ||
|---|---|---|
| Gross margin | 55.2% | 86.8%▲ best |
| Operating margin | 13.1%▲ best | -41.1% |
| Net margin | 9.4%▲ best | -43.6% |
| Return on equity | 4.5% | — |
| Growth | ||
|---|---|---|
| Revenue growth | 4.9% | 27.2%▲ best |
| Revenue growth, 3 years a year | 6.1% | 55.1%▲ best |
| Earnings per share growth | -3.4% | — |
| Financial strength | ||
|---|---|---|
| Debt to equity | 0.2× | — |
| Cash | ||
|---|---|---|
| Free cash flow margin | 16.6%▲ best | -25.8% |
| Altman Z-score zone | — | distress |
|---|
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.